Tech Company Financing Transactions

T-Therapeutics Funding Round

F-Prime Capital, Sofinnova Partners and Cambridge Innovation Capital participated in a $59.8 million Series A venture round for T-Therapeutics. The funding round was announced on 11/16/2023.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

Suite 1 Riverside 3 Granta Park
Cambridge, England, CB21 6AD
UK

Phone

Undisclosed

Website

www.t-therapeutics.com

Email Address

[email protected]

Overview

T-Therapeutics is developing a pipeline of first-in-class drugs that will become transformative medicines, reshaping the clinical landscape for patients with cancer or autoimmune diseases.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Allan Bradley

        

Chief Financial Officer

Alison Lloyd

        

Browse more venture capital transactions:

Prev: 11/15/2023: Le Fourgon venture capital transaction
Next: 11/16/2023: Siena AI venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary